Definitive Contract HHSF223201610091C
Award Date 9/6/16
Potential Completion Date 9/20/19
Potential Value $549K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Lafayette, IN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
68
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price federal contract awarded by the Food and Drug Administration (FDA) to Akina, Inc., a minority-owned, for-profit, Asian-Pacific American manufacturer located in West Lafayette, Indiana. The contract, valued at $1,211,682.00, is for the development of new analytical methods for mini-size complex long-acting injectable formulations, specifically poly(lactide-co-glycolide) (PLGA) formulations. This contract aims to advance the FDA's regulatory science and innovation goals,...
- This is a $208,489 firm-fixed-price definitive contract awarded by the National Cancer Institute, part of the U.S. Department of Health and Human Services, to Akina, Inc., a minority-owned, for-profit, Asian-Pacific American manufacturer based in West Lafayette, Indiana. The contract has a total small business set-aside designation and a performance period ending on June 15, 2015. The contract supports the development of new analytical methods for complex long-acting injectable formulations,...
- This federal contract award was made by the Food and Drug Administration (FDA), a civilian agency, to Qrono, Inc., a for-profit company specializing in medical and scientific research and development. The $694,584.58 cost-plus-fixed-fee contract, titled "Computational Drug Delivery: Leveraging Predictive Models to Develop Bioequivalent Generic Long-Acting Injections," is focused on developing innovative drug delivery systems and immunotherapy approaches. The contract has an ultimate...
- This federal contract award, HHSN271201600200P, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The $114,640 firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business. The contract is set aside for small businesses and supports the use of mouse knockout models to determine the function of...
- This is a new task order awarded under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSF223201610004I) with the Department of Health and Human Services Food and Drug Administration (FDA). The task order, valued at $2,470,791.00, is for a Pharmacokinetic (PK) study of opioid drug products following oral ingestion of chewed products. The study falls under the FDA's In Vivo Study of Generic Drug Products in Human Subjects program. The contract is a Firm Fixed Price...
- The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
- This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Akira Technologies Inc., a minority-owned, self-certified small disadvantaged business. The contract, valued at $1,238,150.15, is for the development of the FSMA Assessment Tool (FAT) under the Food Safety Modernization Act (FSMA). The contract is an 8(a) sole source award, meaning it was set aside for 8(a) small businesses. Akira Technologies is registered in the System for Award...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,877,830 firm fixed price delivery order contract to Biopharma Services USA Inc. for NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS. As a foreign owned, self-certified small disadvantaged business, Biopharma Services USA will conduct the in vivo study of generic drug products in human subjects to fulfill the FDA's major program of...
- The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded a Delivery Order contract worth $89,535.83 to Akira Technologies Inc. to replace NIDA's existing C7000 virtualization environment. This contract is issued under the Chief Information Officer Commodities and Solutions (CIO-CS) Government-Wide Acquisition Contract (GWAC), a multiple-award, indefinite-delivery, indefinite-quantity contract vehicle managed by the National...
- This is a federal contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Akira Technologies Inc., a minority-owned, self-certified small disadvantaged business. The contract, valued at $3,096,924.39, is for digital management and business solutions support for the FDA. The contract vehicle used is the 8(a) Streamlined Technology Acquisition Resources for Services (8(a) STARS II) Government-Wide Acquisition Contract (GWAC), which provides IT...